Avalo Therapeutics, Inc.
Nasdaq · CIK 0001534120 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Avalo Therapeutics, Inc. | 2026-07-29 | 0001918845-26-000024 |
| 4 | Avalo Therapeutics, Inc. | 2026-07-02 | 0001918845-26-000022 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-25 | 0001918845-26-000020 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-12 | 0001918845-26-000018 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-12 | 0002047607-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-12 | 0001677896-26-000008 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-12 | 0001810417-26-000016 |
| 4 | Avalo Therapeutics, Inc. | 2026-06-01 | 0001918845-26-000016 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-26 | 0002047607-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-26 | 0001810417-26-000014 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-26 | 0001677896-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-26 | 0001918845-26-000014 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-26 | 0001586785-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-19 | 0001918845-26-000012 |
| 10-Q | Avalo Therapeutics, Inc. | 2026-05-13 | 0001534120-26-000033 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-11 | 0001810417-26-000012 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-07 | 0001677896-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-07 | 0001810417-26-000010 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-07 | 0001918845-26-000010 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-07 | 0001789335-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-05-01 | 0001810417-26-000008 |
| 4 | Avalo Therapeutics, Inc. | 2026-04-08 | 0001918845-26-000008 |
| 4 | Avalo Therapeutics, Inc. | 2026-04-03 | 0001810417-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-04-03 | 0001918845-26-000006 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0001247024-26-000002 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0001586785-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0001810417-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0001789335-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0002017156-26-000002 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0002013869-26-000002 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-31 | 0001862734-26-000002 |
| 10-K | Avalo Therapeutics, Inc. | 2026-03-23 | 0001534120-26-000011 |
| 4 | Avalo Therapeutics, Inc. | 2026-03-18 | 0001918845-26-000004 |
| 4 | Avalo Therapeutics, Inc. | 2025-12-12 | 0001470831-25-000412 |
| 4 | Avalo Therapeutics, Inc. | 2025-12-12 | 0001470831-25-000411 |
| 4 | Avalo Therapeutics, Inc. | 2025-12-12 | 0001470831-25-000410 |
| 4 | Avalo Therapeutics, Inc. | 2025-12-12 | 0001470831-25-000409 |
| 4 | Avalo Therapeutics, Inc. | 2025-11-17 | 0002013869-25-000002 |
| 10-Q | Avalo Therapeutics, Inc. | 2025-11-06 | 0001534120-25-000018 |
| 10-Q | Avalo Therapeutics, Inc. | 2025-08-07 | 0001628280-25-038575 |